PTEN and cancer: PTEN is deficient or downregulated in several cancers, such as endometrial carcinoma [23], glioblastoma multiforme [24, 25], skin cancer [26], breast cancer [27], prostate cancer [28], and lung cancer [29]; therefore, elevated levels of PIP3 promote cellular growth and proliferation while suppressing apoptosis [23–30].